Seeing Is Believing
ADIL is currently covered by 1 analysts with an average price target of $1.91. This is a potential upside of $-0.33 (-14.73%) from yesterday's end of day stock price of $2.24.
Adial Pharmaceuticals's activity chart (see below) currently has 0 price targets and 2 ratings on display. The stock rating distribution of ADIL is 100% HOLD.
Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 384.33 days.
Highest price target for ADIL is $14, Lowest price target is $14, average price target is $1.91.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 17-Aug-2022. First documented stock forecast 29-Jun-2021.
Currently out of the existing stock ratings of ADIL, 1 are a HOLD (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
5
1 years 8 months 2 days ago
1/1 (100%)
$-15.84 (-76.01%)
384
Buy
12
$9.22 (331.65%)
2 years 6 months 5 days ago
0/1 (0%)
$8.01 (200.75%)
Buy
15
$12.22 (439.57%)
5
2 years 7 months 24 days ago
1/2 (50%)
$6.85 (199.04%)
769
What is ADIL (Adial Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ADIL (Adial Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on ADIL (Adial Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ADIL (Adial Pharmaceuticals)?
Which analyst is the currently most bullish on ADIL (Adial Pharmaceuticals)?
Which analyst is the currently most reserved on ADIL (Adial Pharmaceuticals)?